Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P56
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -1.96% |
| Q3 2025 | 1.64% |
| Q2 2025 | 5.38% |
| Q1 2025 | -26.02% |
| Q4 2024 | 8.09% |
| Q3 2024 | -46.83% |
| Q2 2024 | -4.06% |
| Q1 2024 | -2.17% |
| Q4 2023 | -8.70% |
| Q3 2023 | 6.69% |
| Q2 2023 | -46.79% |
| Q1 2023 | -13.25% |
| Q4 2022 | 5.05% |
| Q3 2022 | 19.86% |
| Q2 2022 | -47.43% |
| Q1 2022 | 31.13% |
| Q4 2021 | -21.50% |
| Q3 2021 | -41.77% |
| Q2 2021 | -20.02% |
| Q1 2021 | 12.12% |
| Q4 2020 | -111.54% |
| Q3 2020 | -55.85% |
| Q2 2020 | -10.47% |
| Q1 2020 | -43.56% |
| Q4 2019 | -50.73% |
| Q3 2019 | -53.58% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2017 | -905.17% |
| Q3 2017 | 190.00% |
| Q2 2017 | 140.82% |
| Q1 2017 | -244.12% |
| Q4 2016 | 129.06% |
| Q3 2016 | 78.80% |
| Q2 2016 | -480.69% |
| Q1 2016 | 1215.38% |
| Q4 2015 | -112.15% |
| Q3 2015 | 970.00% |
| Q2 2015 | 1100.00% |
| Q1 2015 | -103.23% |